{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:53:24Z","timestamp":1777953204084,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.brachy.2021.10.006","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T11:06:29Z","timestamp":1645441589000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Timothy","family":"Griffith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-9352","authenticated-orcid":false,"given":"Chika","family":"Nwachukwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-6518","authenticated-orcid":false,"given":"Kevin","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2021.10.006_bib0001","series-title":"SEER Cancer Statistics Review, 1975-2018","author":"Howlader","year":"2020"},{"issue":"5","key":"10.1016\/j.brachy.2021.10.006_bib0002","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0003","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2021.10.006_bib0004","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.brachy.2021.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2021.10.006_bib0006","unstructured":"National Comprehensive Cancer Network. Uterine Neoplasms (Version 2.2021) Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Accessed May 18."},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0008","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0167-8140(89)90036-4","article-title":"Endometrial carcinoma: high dose-rate brachytherapy in combination with external irradiation; a multivariate analysis of relapses","volume":"16","author":"Lybeert","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0360-3016(90)90133-5","article-title":"Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma","volume":"19","author":"Randall","year":"1990","journal-title":"Int J Radiat Oncology*BiolPhys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0011","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(94)90357-3","article-title":"Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a long-term follow-up","volume":"30","author":"Nori","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0012","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0360-3016(96)00188-5","article-title":"Improved outcome in patients treated with postoperative radiation therapy for pathologic stage III endometrial cancer","volume":"35","author":"Algan","year":"1996","journal-title":"Int J Radiat OncolBiolPhys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1998.5064","article-title":"The role of adjuvant radiotherapy in carcinoma of the endometrium\u2014results in 550 patients with pathologic stage i disease","volume":"70","author":"Irwin","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0014","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00173-4","article-title":"Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?","volume":"42","author":"Greven","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1525-1438.1999.99026.x","article-title":"Adjuvant high-dose rate brachytherapy with or without external beam radiotherapy post-hysterectomy for endometrial cancer","volume":"9","author":"MacLeod","year":"1999","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.brachy.2021.10.006_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/gyno.1999.5380","article-title":"Predictors of recurrence in surgical stage II endometrial adenocarcinoma","volume":"73","author":"Feltmate","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5454","article-title":"Survival of women with surgical stage II endometrial cancer","volume":"74","author":"Eltabbakh","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0018","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(02)02813-4","article-title":"Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients","volume":"53","author":"Pitson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0019","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2004.09.022","article-title":"A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with \"high-risk\" endometrial cancer","volume":"96","author":"Duska","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijrobp.2007.09.022","article-title":"Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns","volume":"71","author":"Cozad","year":"2008","journal-title":"Int J Radiat OncolBiol*Phys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0022","doi-asserted-by":"crossref","unstructured":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. The Lancet2009;373:137\u2013146.","DOI":"10.1016\/S0140-6736(08)61767-5"},{"issue":"2","key":"10.1016\/j.brachy.2021.10.006_bib0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","article-title":"Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma","volume":"113","author":"Cannon","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0024","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2009.03.027","article-title":"Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer","volume":"114","author":"Lupe","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2021.10.006_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3802\/jgo.2014.25.2.105","article-title":"Survival analysis of endometrial cancer patients with cervical stromal involvement","volume":"25","author":"Frandsen","year":"2014","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2021.10.006_bib0027","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/jcb.2015.50877","article-title":"The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer","volume":"7","author":"Huddleston","year":"2015","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2021.10.006_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2021.10.006_bib0029","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2013a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.brachy.2021.10.006_bib0030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0031","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2021.10.006_bib0032","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/AOG.0b013e3181f73fc2","article-title":"Cervical stromal invasion predicting survival in endometrial cancer","volume":"116","author":"Ferriss","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.brachy.2021.10.006_bib0033","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2016.12.035","article-title":"Poppe MM. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement","volume":"97","author":"Bingham","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2007.05.048","article-title":"Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis","volume":"70","author":"Rossi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2021.10.006_bib0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2014.12.034","article-title":"Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study","volume":"136","author":"Mahdi","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0036","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.brachy.2021.10.006_bib0037","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ygyno.2019.03.097","article-title":"Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","volume":"154","author":"Reijnen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0038","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0039","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2015.09.084","article-title":"Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer","volume":"140","author":"Mitra","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.10.006_bib0040","doi-asserted-by":"crossref","unstructured":"Zhang Y., Rovirosa A., Ascaso C., Herreros A., Torne A., Li Y., Biete A., S\u00e1nchez J. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis. Brachytherapy. 2020 Jan-Feb;19(1):60-65. doi: 10.1016\/j.brachy.2019.09.004. Epub 2019 Oct 3. PMID: 31587986.","DOI":"10.1016\/j.brachy.2019.09.004"},{"key":"10.1016\/j.brachy.2021.10.006_bib0041","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology\u2013RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.brachy.2021.10.006_bib0042","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/cncr.29337","article-title":"NRG Oncology\/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer","volume":"121","author":"Viswanathan","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.brachy.2021.10.006_bib0043","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brachy.2019.11.007","article-title":"Time-driven activity-based costing of adjuvant vaginal cuff brachytherapy for uterine cancer in an integrated brachytherapy suite","volume":"19","author":"Su","year":"2020","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2009.07.1692","article-title":"A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.10.006_bib0045","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2021.10.006_bib0046","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3577477","article-title":"Radiation dose and second cancer risk in patients treated for cancer of the cervix","volume":"116","author":"Boice","year":"1988","journal-title":"Radiat Res"},{"key":"10.1016\/j.brachy.2021.10.006_bib0047","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L","article-title":"Second primary cancer after treatment for cervical cancer. an international can-cer registries study","volume":"76","author":"Kleinerman","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0048","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.10.006_bib0049","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CMAR.S119125","article-title":"Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?","volume":"9","author":"Sabater","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"issue":"10","key":"10.1016\/j.brachy.2021.10.006_bib0051","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/cancers12103059","article-title":"EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.brachy.2021.10.006_bib0052","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s12094-019-02255-z","article-title":"Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?","volume":"22","author":"Zhang","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0053","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.brachy.2019.03.001","article-title":"Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?","volume":"18","author":"Ager","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.10.006_bib0054","first-page":"480","article-title":"Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma","volume":"67","author":"Fayed","year":"2007","journal-title":"Inte JRadiat OncolBiolPhys"},{"issue":"1","key":"10.1016\/j.brachy.2021.10.006_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12957-019-1620-x","article-title":"Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma","volume":"17","author":"Veade","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2021.10.006_bib0056","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s00261-020-02453-2","article-title":"Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy","volume":"45","author":"Steiner","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.brachy.2021.10.006_bib0057","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/IGC.0b013e3182a16c93","article-title":"Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer","volume":"23","author":"Weinberg","year":"2013","journal-title":"Int J Gynecol Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121005274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121005274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:16:55Z","timestamp":1761531415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121005274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1538472121005274"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.10.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}